SEC 13F Intelligence

Managers / Q3 2021 · view latest →

Centerbridge Partners, L.P.

CIK 0001484836 · 375 PARK AVENUE, 11TH FLOOR, NEW YORK, NY, 10152 · 212 672 5000

Reported Value
$856M
Q3 2021
Positions
108
Filings on Record
33
2019–present window
Filed
Nov 15, 2021
original filing

Summary

Centerbridge Partners, L.P. reported $856M in U.S.-listed holdings across 108 positions for Q3 2021.

The portfolio is heavily concentrated: Gohealth alone accounts for 23.9% of reported value.

Compared with Q2 2021, the fund opened 2 new positions and exited 9.

Portfolio Metrics

Turnover
+14.5%
vs prior filed quarter
Top-10 Concentration
+87.3%
share of reported value
Largest Position
+23.9%
Gohealth
New / Exited
2 / 9
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $982MQ4 ’18Q1 ’19: $729MQ2 ’19: $815MQ3 ’19: $550MQ4 ’19: $618MQ4 ’19Q1 ’20: $412MQ2 ’20: $468MQ3 ’20: $894MQ4 ’20: $1.2BQ4 ’20Q1 ’21: $1.1BQ2 ’21: $1.1BQ3 ’21: $856MQ4 ’21: $1.8BQ4 ’21Q1 ’22: $1.6BQ2 ’22: $1.1BQ3 ’22: $875MQ4 ’22: $1.0BQ4 ’22Q1 ’23: $1.0BQ2 ’23: $642MQ3 ’23: $467MQ4 ’23: $604MQ4 ’23Q1 ’24: $623MQ2 ’24: $505MQ3 ’24: $478MQ4 ’24: $468MQ4 ’24Q1 ’25: $510MQ2 ’25: $434MQ3 ’25: $101MQ4 ’25: $59MQ4 ’25Q1 ’26: $61Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 54.7%Other: 34.1%ETP: 9.2%ADR: 2.1%Equity WRT: 0.0%
  • Common Stock · 54.7% · $468M
  • Other · 34.1% · $291M
  • ETP · 9.2% · $79M
  • ADR · 2.1% · $18M
  • Equity WRT · 0.0% · $14,000

Quarter-over-Quarter Changes full breakdown →

vs Q2 2021 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
IWMISHARES TRNEW+360.0K360.0K+$79M$79M
CEDAR FAIR L PNEW+688.6K688.6K+$32M$32M
GDSGDS HLDGS LTDADDED+175.0K310.0K+$7M$18M
PCGPG&E CORPSOLD OUT6.65M0$68M$0
ROOT INCSOLD OUT1.25M0$14M$0
EIXEDISON INTLSOLD OUT143.5K0$8M$0
SOARING EAGLE ACQUISITION COSOLD OUT200.0K0$2M$0
NOVUS CAPITAL CORPORATION IISOLD OUT150.0K0$1M$0

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2021

36 positions
#IssuerClass% PortfolioValueShares
1GOHEALTH INCCOM CL A23.91%$205M40.68M
2RADIUS GLOBAL INFRASTRCTRE ICOM CL A20.85%$178M10.93M
3THCTENET HEALTHCARE CORPhistory →COM NEW17.26%$148M2.22M
4GNKGENCO SHIPPING & TRADING LTDhistory →SHS10.74%$92M4.56M
5CEDAR FAIR L PDEPOSITRY UNIT3.73%$32M688.6K
6GTXGARRETT MOTION INChistory →COM2.92%$25M3.39M
7CYHCOMMUNITY HEALTH SYS INC NEWhistory →COM2.92%$25M2.13M
8VECTOIQ ACQUISITION CORP IICOM CL A · *W EXP 01/07/2022.25%$19M2.34M
9GDSGDS HLDGS LTDhistory →SPONSORED ADS2.05%$18M310.0K
10AF ACQUISITION CORPCLASS A COM · *W EXP 03/23/2020.70%$6M800.0K
11LANDCADIA HOLDINGS IV INCCLASS A COM · *W EXP 03/29/2020.58%$5M625.0K
12BUILD ACQUISITION CORPCOM CLASS A · *W EXP 03/15/2020.52%$4M600.0K
13CC NEUBERGER PRINCIPAL HOLDNSHS CL A · *W EXP 99/99/9990.47%$4M480.0K
14CF ACQUISITION CORP IVCOM CL A · *W EXP 12/31/2020.20%$2M263.0K
15SPARTAN ACQUISITION CORP IIICOM CL A · *W EXP 02/04/2020.18%$2M187.5K
16CF ACQUISITION CORP VICOM CL A · *W EXP 02/18/2020.17%$1M187.5K
17ALTIMETER GROWTH CORP 2COM CL A0.17%$1M150.0K
18BIOTECH ACQUISITION COMPANYCL A SHS · *W EXP 11/30/2020.12%$1M150.0K
19SCP & CO HEALTHCARE ACQUSTNCOM CL A · *W EXP 01/27/2020.12%$1M150.0K
20COLICITY INCCOM CL A · *W EXP 02/24/2020.12%$994,000120.0K
21CROWN PROPTECH ACQUISITIONSSHS CL A · *W EXP 99/99/9990.12%$993,000133.3K
22HUDSON EXECUTIVE INVES IIICOM CL A · *W EXP 02/22/2020.12%$990,000120.0K
23DIAMONDHEAD HOLDINGS CORPCL A · *W EXP 01/28/2020.12%$988,000125.0K
24RXR ACQUISITION CORPCLASS A COM · *W EXP 03/08/2020.12%$987,000120.0K
25CF ACQUISITION CORP VCL A0.10%$881,00089.0K
26FIGURE ACQUISITION CORP ICOM CL A · *W EXP 03/31/2020.06%$519,00075.0K
27ARES ACQUISITION CORPORATIONCOM CL A · *W EXP 99/99/9990.06%$504,00070.0K
28EQHAWEQ HEALTH ACQUISITION CORPCOM CL A · *W EXP 02/02/2020.06%$502,00075.0K
29PROVIDENT ACQUISITION CORPCL A · *W EXP 01/08/2020.05%$413,000112.7K
30DUNE ACQUISITION CORP*W EXP 10/29/2020.01%$98,000150.0K
31NOVUS CAPITAL CORPORATION II*W EXP 02/02/2020.01%$54,00050.0K
327GC & CO HOLDINGS INC*W EXP 12/23/2020.01%$54,00092.5K
33DEEP LAKE CAPITAL ACQUSTN CO*W EXP 01/04/2020.01%$46,00060.0K
34HEALTHCARE CAPITAL CORP*W EXP 12/31/2020.00%$35,00050.0K
35FORTRESS CAPITAL ACQUISITION*W EXP 99/99/9990.00%$26,00030.0K
36INSU ACQUISITION CORP III*W EXP 12/31/2020.00%$26,00033.3K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$61M3May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$59M2Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$101M4Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$434M9Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$510M11May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$468M13Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$478M15Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$505M17Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$623M20May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$604M20Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$467M25Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$642M27Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$1.0B29May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$1.0B34Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$875M62Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$1.1B67Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$1.6B71May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$1.8B111Feb 17, 2022RESTATEMENTchanges · EDGAR ↗
Q3 2021$856M108Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$1.1B124Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$1.1B109May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$1.2B36Feb 23, 2021RESTATEMENTchanges · EDGAR ↗
Q3 2020$894M23Nov 17, 202013F-HRchanges · EDGAR ↗
Q2 2020$468M33Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$412M40May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$618M17Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$550M22Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$815M20Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$729M26May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$982M37Feb 14, 201913F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 10 additional managers.

  • Centerbridge Credit Advisors, L.L.C.028-13862
  • Centerbridge Partners Holdings, LLC028-13861
  • Aronson Jeffrey028-13858
  • Gallogly Mark T028-13857
  • Centerbridge Special Credit Advisors, L.L.C.028-14395
  • Centerbridge Advisors, LLC028-15424
  • Centerbridge Special Credit Advisors II, L.L.C028-16779
  • Centerbridge Special Credit Advisors III, L.L.C.028-19382
  • Centerbridge Advisors II, LLC028-20085
  • Centerbridge Advisors III, LLC028-21012

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.